Success Metrics

Clinical Success Rate

100.0%

Based on 12 completed trials

Completion Rate

100%(12/12)

Active Trials

1(7%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution14 total trials

N/ANon-phased studies

14(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(12)

Detailed Status

Completed12

Recruiting1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A14 (100.0%)

Trials by Status

recruiting17%

completed1286%

not_yet_recruiting17%

Recent Activity

1 active trials

Showing 5 of 14

not_yet_recruitingnot_applicable

Inulin-Spirulina Co-intervention for Insomnia Disorder

NCT07537192

recruitingnot_applicable

Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury

NCT07263217

completednot_applicable

Spirulina (FEM-102) Supplement to Chronic Hepatitis B Patients

NCT04718831

completednot_applicable

Spirulina Supplementation and Cardiovascular Risk in Obese Caucasians With Treated Hypertension

NCT02575690

completednot_applicable

Effects of Spirulina Supplementation on Overweight or Obese Adults

NCT02993627

View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials

NCT07537192Not Applicable

Inulin-Spirulina Co-intervention for Insomnia Disorder

Not Yet Recruiting

NCT07263217Not Applicable

Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury

Recruiting

NCT04718831Not Applicable

Spirulina (FEM-102) Supplement to Chronic Hepatitis B Patients

Completed

NCT02575690Not Applicable

Spirulina Supplementation and Cardiovascular Risk in Obese Caucasians With Treated Hypertension

Completed

NCT02993627Not Applicable

Effects of Spirulina Supplementation on Overweight or Obese Adults

Completed

NCT02744547Not Applicable

Effect of Spirulina on Serum Hyaluronic Acid in Beta Thalassemic Children With Hepatitis C

Completed

NCT03523182Not Applicable

Spirulina Supplementation and Infant Growth, Morbidity and Motor Development

Completed

NCT03380611Not Applicable

Algae and Cholesterol Absorption

Completed

NCT02744105Not Applicable

Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C

Completed

NCT02744560Not Applicable

Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C

Completed

NCT02597595Not Applicable

Effects of Spirulina on Cardiac Functions in Children With Beta Thalassemia Major

Completed

NCT02671695Not Applicable

Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia

Completed

NCT02674607Not Applicable

the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children

Completed

NCT01752972Not Applicable

Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to Arsenic

Completed

All 14 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 14